News of Note—Novavax, Walter Reed and more


Here is some other vaccine news of note for the week:

> Novavax has enrolled the first participants in a phase 2 study of its NanoFlu in older adults. Release

> The Walter Reed Army Institute of Research signed a deal with Enesi Pharma for the development of a needle-free Shigella vaccine. Release

Virtual Clinical Trials Summit

Virtual Clinical Trials Summit: The Premier Educational Event Focused on Decentralized Clinical Trials

In this virtual environment, we will look at current and future trends for ongoing virtual trials, diving into the many ways companies can improve patient engagement and trial behavior to enhance retention with a focus on emerging technology and harmonized data access across the clinical trial system.

> The Biomedical Advanced Research and Development Authority awarded Altimmune an additional $2.5 million to support work on its anthrax vaccine candidate NasoShield. Release

> LineaRx, a subsidiary of Applied DNA, signed on with Takis and Evvivax to developed DNA-based cancer vaccines. Release